Patient-reported Outcomes Following Percutaneous Ablation of Desmoid Tumors

Conditions

• Aggressive Fibromatoses
• Desmoid Tumor

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Desmoid tumor ablation — PROCEDURE
  Percutaneous ablation of desmoid tumor

Study Details

This study will evaluate patient-reported outcomes before and after percutaneous ablation of desmoid tumors. Adult participants undergoing ablation for desmoid tumor will complete surveys pre and post procedure to assess symptom burden, impact on daily life, early post-procedural pain and recovery, concomitant treatments, and radiological response following ablation.

Key Dates

First listed

Aug 10, 2026

Start date

Sep 1, 2026

Status verified

Aug 2026

Primary completion

Dec 31, 2028

Completion

Dec 31, 2028

Study Design

Enrollment

30 participants (estimated)

Arms

• Arm: Desmoid Tumor Ablation Cohort
  Adult participants undergoing percutaneous ablation for desmoid tumor who complete patient-reported outcome surveys before and after treatment.

Primary Outcome Measure

Change in desmoid tumor symptom severity following ablation [ Time Frame: Baseline; 7 days; 1, 3, 6, 12, and 24 months post-ablation ]

Locations (1)

Find similar trials in Rochester, MN

Related Studies

• Study of Cryoablation and Nirogacestat for Desmoid Tumor
  PHASE2 · Recruiting · Nam Bui · Palo Alto, California